| Edition |
4th ed. |
| Description |
xxii, 260 p. ; 24 cm. |
| Note |
"A Norton professional book"--P. facing t.p. |
| Bibliography |
Includes bibliographical references (p. 235-242) and index. |
| Contents |
1. Antipsychotics -- Introduction to drug class -- First-generation antipsychotics -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Second-generation antipsychotics -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- Treatment resistance -- Maintenance -- 2. Agents for treating movement disorders -- Introduction to drug class -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- ACA dosage adjustment -- |
|
3. Antidepressants -- Introduction to drug class -- Monoamine oxidase inhibitors -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Transporter inhibitors -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Receptor antagonists/agonists -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- Treatment-resistant depression -- Augmentation and combination therapies -- |
|
4. Dementia-treating agents -- Introduction to drug class -- Cholinesterase inhibitors -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- NMDA antagonist -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- Treatment resistance -- Maintenance -- |
|
5. Mood stabilizers -- Introduction to drug class -- Lithium -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Anticonvulsants -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Treatment initiation -- Treatment resistance -- Maintenance -- |
|
6. Antianxiety agents -- Introduction to drug class -- Benzodiazepines -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Nonbenzodiazepines -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- Treatment resistance -- Maintenance -- |
|
7. Hypnotics -- Introduction to drug classes -- Hypnotic benzodiazepines and selective benzodiazepine-1 receptor agonists -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Selective melatonin agonist -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Barbiturates and barbiturate-like compounds -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Additional sleep-promoting agents -- Therapeutic application -- Initiation of treatment -- Maintenance -- |
|
8. Stimulants and stimulant-like agents -- Introduction to drug class -- First-generation stimulants -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Second-generation stimulants -- Dosing, dose form, and color -- Pharmacology -- Clinical indications -- Side effects -- Drug and food interactions -- Special populations -- Effects on laboratory tests -- Discontinuation -- Overdose : toxicity, suicide, and treatment -- Precautions -- Key points to communicate to patients and families -- Therapeutic application -- Initiation of treatment -- Treatment resistance -- Maintenance -- Appendices -- 1. Drug identification by generic name -- 2. Drug identification by trade name -- 3. Drug interactions - cytochrome P450 enzymes -- 4. Measurement-based care. |
| Subject |
Psychotropic drugs -- Handbooks, manuals, etc.
|
|
Psychotropic Drugs -- Handbooks. |
| Added Author |
Kennedy, Sidney H.
|
|
McIntyre, Roger S.
|
| ISBN |
9780393705201 (hbk.) |
|
039370520X (hbk.) |
|
